July 5, 2024
How Could a New Longevity Medicine Create $200B Per Year in Revenue? Dr. Greg Bailey and I asked top VC Alex Colville from age1
What can we learn from an investor who has deployed over $100 million into longevity-focused biotech startups? Alex Colville shares his biggest takeaways, from the importance of founder-market fit to the need to challenge assumptions in a nascent field.